{"id":28986,"date":"2020-11-03T19:09:05","date_gmt":"2020-11-04T00:09:05","guid":{"rendered":"https:\/\/wfh.org\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/"},"modified":"2024-04-21T12:47:40","modified_gmt":"2024-04-21T16:47:40","slug":"takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires","status":"publish","type":"post","link":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/","title":{"rendered":"Takeda interrompt le recrutement de ses \u00e9tudes de th\u00e9rapie g\u00e9nique \u00e0 des fins d\u2019\u00e9valuation des donn\u00e9es provisoires"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"28986\" class=\"elementor elementor-28986 elementor-16407\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-de69241 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"de69241\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2e8fb4d\" data-id=\"2e8fb4d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0d39d9f elementor-widget elementor-widget-text-editor\" data-id=\"0d39d9f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"\">Takeda a suspendu la s\u00e9lection et le recrutement des \u00e9tudes cliniques de ses th\u00e9rapies g\u00e9niques\u00a0AAV8 pour le traitement de l\u2019h\u00e9mophilie\u00a0A et B. Takeda a indiqu\u00e9 dans son courrier adress\u00e9 \u00e0 la FMH que la d\u00e9cision ne r\u00e9sultait pas de pr\u00e9occupations li\u00e9es \u00e0 la s\u00e9curit\u00e9 concernant TAK-754 et TAK-748. \u00ab\u00a0Nous \u00e9valuons actuellement les donn\u00e9es provisoires de l\u2019\u00e9tude de phase\u00a0I\/II en cours portant sur TAK-754 dans l\u2019h\u00e9mophilie\u00a0A, parall\u00e8lement au paysage actuel global de la th\u00e9rapie g\u00e9nique dans l\u2019h\u00e9mophilie,\u00a0\u00bb a expliqu\u00e9 Takeda. Les patients recrut\u00e9s resteront sous observation clinique \u00e9troite conform\u00e9ment au protocole de l\u2019\u00e9tude et ceux qui devaient \u00eatre inclus dans ces \u00e9tudes feront l\u2019objet d\u2019une transition. Aucun patient n\u2019a encore re\u00e7u de traitement dans l\u2019\u00e9tude de phase\u00a0I\/II de TAK-748 dans l\u2019h\u00e9mophilie\u00a0B. Takeda tiendra la communaut\u00e9 inform\u00e9e d\u00e8s lors qu\u2019il aura termin\u00e9 son \u00e9valuation.<\/p>\r\n\r\n<p class=\"\">Nous reprenons ici le courrier de Takeda (en anglais)&nbsp;:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c5de3da elementor-widget elementor-widget-text-editor\" data-id=\"c5de3da\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"\">19 August 2020<\/p>\r\n\r\n<p class=\"\">TAK-754 and TAK-748 Clinical Studies<\/p>\r\n\r\n<p class=\"\">As one of our partners we work closely with, we are writing today to share an important update with you on Takeda\u2019s gene therapy in hematology. Takeda has recently made the decision to suspend screening and further enrollment in the TAK-754 and TAK-748 clinical studies, effective immediately.<\/p>\r\n\r\n<p class=\"\">As you may know, TAK-754 is an AAV8 gene therapy for the treatment of hemophilia A currently in Phase 1\/2 clinical development, while TAK-748 is an AAV8 gene therapy for the treatment of hemophilia B in Phase 1\/2 study start-up (no subject dosed as of today). In order to determine the most appropriate way forward for both TAK-754 and TAK-748, we are currently assessing the interim data from the ongoing Phase 1\/2 study of TAK-754 in hemophilia A, together with the overall current gene therapy landscape in hemophilia. We will communicate more details on these results to the community in due time once our assessment has been finalized. It is important to note that this decision is not a result of any safety concerns with TAK-754 and TAK-748.<\/p>\r\n\r\n<p class=\"\">We have informed those investigators who are working directly on these studies. Our priority first and foremost, is to ensure the safety and wellbeing of patients. Those who are enrolled will continue to be under close clinical observation according to study protocol, and those who were planned to be enrolled into these studies will be informed and transitioned. We would like to emphasize that we remain committed to advancing gene therapies and very much believe in their potential. Our strategy is focused on delivering novel and transformative medicines to patients, and we will continue to work with our gene therapy platforms with the aim of delivering treatments in the future that can help make a meaningful difference in those living with hemophilia and other rare hematological diseases. We hope to continue the dialogue with your organization to help us inform that innovative focus.<\/p>\r\n\r\n<p class=\"\">We are proud to be a long-standing leader in bleeding disorders, and of our relation with the World Federation of Hemophilia of almost 30 years, which is grounded in our common goal to improve standards of care around the world. Takeda\u2019s vision for a bleed-free world continues to fuel our passion every day to make a difference in the lives of those affected by bleeding disorders. Working together we hope to achieve it.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Takeda a suspendu la s\u00e9lection et le recrutement des \u00e9tudes cliniques de ses th\u00e9rapies g\u00e9niques\u00a0AAV8 pour le traitement de l\u2019h\u00e9mophilie\u00a0A et B. Takeda a indiqu\u00e9 dans son courrier adress\u00e9 \u00e0 [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":19564,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[203],"tags":[],"search-category":[],"class_list":["post-28986","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gene-therapy-fr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Takeda interrompt le recrutement de ses \u00e9tudes de th\u00e9rapie g\u00e9nique \u00e0 des fins d\u2019\u00e9valuation des donn\u00e9es provisoires | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Takeda interrompt le recrutement de ses \u00e9tudes de th\u00e9rapie g\u00e9nique \u00e0 des fins d\u2019\u00e9valuation des donn\u00e9es provisoires\" \/>\n<meta property=\"og:description\" content=\"Takeda a suspendu la s\u00e9lection et le recrutement des \u00e9tudes cliniques de ses th\u00e9rapies g\u00e9niques\u00a0AAV8 pour le traitement de l\u2019h\u00e9mophilie\u00a0A et B. Takeda a indiqu\u00e9 dans son courrier adress\u00e9 \u00e0 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/\" \/>\n<meta property=\"og:site_name\" content=\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/wfhemophilia\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-04T00:09:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-21T16:47:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Electra Rozakis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Electra Rozakis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/\"},\"author\":{\"name\":\"Electra Rozakis\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/622f4b0ed56b8e4a987dd20bef774887\"},\"headline\":\"Takeda interrompt le recrutement de ses \u00e9tudes de th\u00e9rapie g\u00e9nique \u00e0 des fins d\u2019\u00e9valuation des donn\u00e9es provisoires\",\"datePublished\":\"2020-11-04T00:09:05+00:00\",\"dateModified\":\"2024-04-21T16:47:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/\"},\"wordCount\":595,\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png\",\"articleSection\":[\"Th\u00e9rapie g\u00e9nique\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/\",\"url\":\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/\",\"name\":\"Takeda interrompt le recrutement de ses \u00e9tudes de th\u00e9rapie g\u00e9nique \u00e0 des fins d\u2019\u00e9valuation des donn\u00e9es provisoires | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png\",\"datePublished\":\"2020-11-04T00:09:05+00:00\",\"dateModified\":\"2024-04-21T16:47:40+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/#primaryimage\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png\",\"width\":1920,\"height\":1080},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wfh.org\/fr\/#website\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"name\":\"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie\",\"description\":\"WFH - World Federation of Hemophilia\",\"publisher\":{\"@id\":\"https:\/\/wfh.org\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wfh.org\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wfh.org\/fr\/#organization\",\"name\":\"World Federation of Hemophilia\",\"url\":\"https:\/\/wfh.org\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"width\":210,\"height\":63,\"caption\":\"World Federation of Hemophilia\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/wfhemophilia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/wfh.org\/fr\/#\/schema\/person\/622f4b0ed56b8e4a987dd20bef774887\",\"name\":\"Electra Rozakis\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Takeda interrompt le recrutement de ses \u00e9tudes de th\u00e9rapie g\u00e9nique \u00e0 des fins d\u2019\u00e9valuation des donn\u00e9es provisoires | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/","og_locale":"fr_FR","og_type":"article","og_title":"Takeda interrompt le recrutement de ses \u00e9tudes de th\u00e9rapie g\u00e9nique \u00e0 des fins d\u2019\u00e9valuation des donn\u00e9es provisoires","og_description":"Takeda a suspendu la s\u00e9lection et le recrutement des \u00e9tudes cliniques de ses th\u00e9rapies g\u00e9niques\u00a0AAV8 pour le traitement de l\u2019h\u00e9mophilie\u00a0A et B. Takeda a indiqu\u00e9 dans son courrier adress\u00e9 \u00e0 [&hellip;]","og_url":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/","og_site_name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","article_publisher":"https:\/\/www.facebook.com\/wfhemophilia\/","article_published_time":"2020-11-04T00:09:05+00:00","article_modified_time":"2024-04-21T16:47:40+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png","type":"image\/png"}],"author":"Electra Rozakis","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Electra Rozakis","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/#article","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/"},"author":{"name":"Electra Rozakis","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/622f4b0ed56b8e4a987dd20bef774887"},"headline":"Takeda interrompt le recrutement de ses \u00e9tudes de th\u00e9rapie g\u00e9nique \u00e0 des fins d\u2019\u00e9valuation des donn\u00e9es provisoires","datePublished":"2020-11-04T00:09:05+00:00","dateModified":"2024-04-21T16:47:40+00:00","mainEntityOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/"},"wordCount":595,"publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png","articleSection":["Th\u00e9rapie g\u00e9nique"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/","url":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/","name":"Takeda interrompt le recrutement de ses \u00e9tudes de th\u00e9rapie g\u00e9nique \u00e0 des fins d\u2019\u00e9valuation des donn\u00e9es provisoires | FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","isPartOf":{"@id":"https:\/\/wfh.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/#primaryimage"},"image":{"@id":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png","datePublished":"2020-11-04T00:09:05+00:00","dateModified":"2024-04-21T16:47:40+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/article\/takeda-interrompt-le-recrutement-de-ses-etudes-de-therapie-genique-a-des-fins-devaluation-des-donnees-provisoires\/#primaryimage","url":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2022\/01\/Placeholder-Result-V1.png","width":1920,"height":1080},{"@type":"WebSite","@id":"https:\/\/wfh.org\/fr\/#website","url":"https:\/\/wfh.org\/fr\/","name":"FMH - F\u00e9d\u00e9ration mondiale de l\u2019h\u00e9mophilie","description":"WFH - World Federation of Hemophilia","publisher":{"@id":"https:\/\/wfh.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wfh.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/wfh.org\/fr\/#organization","name":"World Federation of Hemophilia","url":"https:\/\/wfh.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","width":210,"height":63,"caption":"World Federation of Hemophilia"},"image":{"@id":"https:\/\/wfh.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/wfhemophilia\/"]},{"@type":"Person","@id":"https:\/\/wfh.org\/fr\/#\/schema\/person\/622f4b0ed56b8e4a987dd20bef774887","name":"Electra Rozakis"}]}},"_links":{"self":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/28986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/comments?post=28986"}],"version-history":[{"count":0,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/posts\/28986\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media\/19564"}],"wp:attachment":[{"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/media?parent=28986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/categories?post=28986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/tags?post=28986"},{"taxonomy":"search-category","embeddable":true,"href":"https:\/\/wfh.org\/fr\/wp-json\/wp\/v2\/search-category?post=28986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}